"Hypersensitivity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen.
| Descriptor ID |
D006967
|
| MeSH Number(s) |
C20.543
|
| Concept/Terms |
Allergic Reaction- Allergic Reaction
- Allergic Reactions
- Reaction, Allergic
- Reactions, Allergic
|
Below are MeSH descriptors whose meaning is more general than "Hypersensitivity".
Below are MeSH descriptors whose meaning is more specific than "Hypersensitivity".
This graph shows the total number of publications written about "Hypersensitivity" by people in this website by year, and whether "Hypersensitivity" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2003 | 0 | 2 | 2 |
| 2004 | 1 | 0 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2008 | 4 | 0 | 4 |
| 2009 | 0 | 2 | 2 |
| 2010 | 0 | 2 | 2 |
| 2011 | 2 | 0 | 2 |
| 2015 | 1 | 0 | 1 |
| 2016 | 2 | 0 | 2 |
| 2017 | 1 | 0 | 1 |
| 2019 | 0 | 2 | 2 |
| 2020 | 2 | 0 | 2 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hypersensitivity" by people in Profiles.
-
Understanding how socioeconomic determinants affect the development of allergy to common foods in children. Ann Allergy Asthma Immunol. 2023 09; 131(3):393-395.
-
The One Health approach for allergic diseases and asthma. Allergy. 2023 07; 78(7):1777-1793.
-
Fellows in Training Wellness in Allergy and Immunology: AAAAI Workgroup Report. J Allergy Clin Immunol Pract. 2022 11; 10(11):2868-2874.
-
Metal-induced delayed type hypersensitivity responses potentiate particle induced osteolysis in a sex and age dependent manner. PLoS One. 2021; 16(5):e0251885.
-
Soy-Based Infant Formula is Associated with an Increased Prevalence of Comorbidities in Fragile X Syndrome. Nutrients. 2020 Oct 14; 12(10).
-
Ipilimumab, nivolumab, and brentuximab vedotin combination therapies in patients with relapsed or refractory Hodgkin lymphoma: phase 1 results of an open-label, multicentre, phase 1/2 trial. Lancet Haematol. 2020 Sep; 7(9):e660-e670.
-
Reply to "Opportunities to enhance the AAAAI Physician Burnout Survey". J Allergy Clin Immunol Pract. 2020 09; 8(8):2839-2840.
-
Work Group Report: COVID-19: Unmasking Telemedicine. J Allergy Clin Immunol Pract. 2020 09; 8(8):2461-2473.e3.
-
Reply. J Allergy Clin Immunol. 2020 07; 146(1):227-228.
-
Reply to "Subcutaneous terbutaline as an alternative to aerosolized albuterol". J Allergy Clin Immunol Pract. 2020 Jul - Aug; 8(7):2450-2452.